APO RESEARCH · REPORT
Myopia Control Spectacle Lenses and Orthokeratology Lens
Selected research
Market Structure
Global Myopia Control Spectacle Lenses and Orthokeratology Lens Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Myopia Control Spectacle Lenses and Orthokeratology Lens market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Myopia Control Spectacle Lenses and Orthokeratology Lens is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Myopia Control Spectacle Lenses and Orthokeratology Lens is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Myopia Control Spectacle Lenses and Orthokeratology Lens is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Myopia Control Spectacle Lenses and Orthokeratology Lens is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Myopia Control Spectacle Lenses and Orthokeratology Lens include HOYA Corporation, ZEISS, CooperVision, EssilorLuxottica, Ovctek, Alpha Corporation, EUCLID, Brighten Optix and Lucid Korea, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Myopia Control Spectacle Lenses and Orthokeratology Lens market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Myopia Control Spectacle Lenses and Orthokeratology Lens and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Myopia Control Spectacle Lenses and Orthokeratology Lens sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Myopia Control Spectacle Lenses and Orthokeratology Lens market size, projected growth trends, production technologies, key applications, and end-use industries.
Myopia Control Spectacle Lenses and Orthokeratology Lens Segment by Company
HOYA Corporation
ZEISS
CooperVision
EssilorLuxottica
Ovctek
Alpha Corporation
EUCLID
Brighten Optix
Lucid Korea
WeiXing Optical
Contex
Jiangsu Green Stone Optical (SETO)
Conant
Myopia Control Spectacle Lenses and Orthokeratology Lens Segment by Type
Myopia Control Spectacle Lenses
Orthokeratology Lens
Myopia Control Spectacle Lenses and Orthokeratology Lens Segment by Application
Children (6-12 Years Old)
Teenagers (12-18 Years Old)
Myopia Control Spectacle Lenses and Orthokeratology Lens Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Myopia Control Spectacle Lenses and Orthokeratology Lens market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Myopia Control Spectacle Lenses and Orthokeratology Lens and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Myopia Control Spectacle Lenses and Orthokeratology Lens.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Myopia Control Spectacle Lenses and Orthokeratology Lens market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Myopia Control Spectacle Lenses and Orthokeratology Lens manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Myopia Control Spectacle Lenses and Orthokeratology Lens in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Myopia Control Spectacle Lenses and Orthokeratology Lens in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Myopia Control Spectacle Lenses
- Orthokeratology Lens
Applications
- Children (6-12 Years Old)
- Teenagers (12-18 Years Old)
Companies covered
- HOYA Corporation
- ZEISS
- CooperVision
- EssilorLuxottica
- Ovctek
- Alpha Corporation
- EUCLID
- Brighten Optix
- Lucid Korea
- WeiXing Optical
- Contex
- Jiangsu Green Stone Optical (SETO)
- Conant
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Market Dynamics
- 2.1 Myopia Control Spectacle Lenses and Orthokeratology Lens Industry Trends
- 2.2 Myopia Control Spectacle Lenses and Orthokeratology Lens Industry Drivers
- 2.3 Myopia Control Spectacle Lenses and Orthokeratology Lens Industry Opportunities and Challenges
- 2.4 Myopia Control Spectacle Lenses and Orthokeratology Lens Industry Restraints
3 Myopia Control Spectacle Lenses and Orthokeratology Lens Market by Manufacturers
- 3.1 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Revenue by Manufacturers (2021-2026)
- 3.2 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Sales by Manufacturers (2021-2026)
- 3.3 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Manufacturers, Product Type & Application
- 3.7 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Myopia Control Spectacle Lenses and Orthokeratology Lens Players Market Share by Revenue in 2025
- 3.8.3 2025 Myopia Control Spectacle Lenses and Orthokeratology Lens Tier 1, Tier 2, and Tier 3
4 Myopia Control Spectacle Lenses and Orthokeratology Lens Market by Type
- 4.1 Myopia Control Spectacle Lenses and Orthokeratology Lens Type Introduction
- 4.1.1 Myopia Control Spectacle Lenses
- 4.1.2 Orthokeratology Lens
- 4.2 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Sales by Type
- 4.2.1 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Sales by Type (2021-2032)
- 4.2.3 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Sales Market Share by Type (2021-2032)
- 4.3 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Revenue by Type
- 4.3.1 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Revenue by Type (2021-2032)
- 4.3.3 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Revenue Market Share by Type (2021-2032)
5 Myopia Control Spectacle Lenses and Orthokeratology Lens Market by Application
- 5.1 Myopia Control Spectacle Lenses and Orthokeratology Lens Application Introduction
- 5.1.1 Children (6-12 Years Old)
- 5.1.2 Teenagers (12-18 Years Old)
- 5.2 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Sales by Application
- 5.2.1 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Sales by Application (2021-2032)
- 5.2.3 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Sales Market Share by Application (2021-2032)
- 5.3 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Revenue by Application
- 5.3.1 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Revenue by Application (2021-2032)
- 5.3.3 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Revenue Market Share by Application (2021-2032)
6 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Sales by Region
- 6.1 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Sales by Region (2021-2032)
- 6.2.1 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Sales by Region (2021-2026)
- 6.2.2 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Myopia Control Spectacle Lenses and Orthokeratology Lens Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Myopia Control Spectacle Lenses and Orthokeratology Lens Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Myopia Control Spectacle Lenses and Orthokeratology Lens Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Myopia Control Spectacle Lenses and Orthokeratology Lens Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Myopia Control Spectacle Lenses and Orthokeratology Lens Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Myopia Control Spectacle Lenses and Orthokeratology Lens Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Myopia Control Spectacle Lenses and Orthokeratology Lens Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Myopia Control Spectacle Lenses and Orthokeratology Lens Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Revenue by Region
- 7.1 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Revenue by Region
- 7.1.1 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Revenue by Region (2021-2026)
- 7.1.3 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Revenue by Region (2027-2032)
- 7.1.4 Global Myopia Control Spectacle Lenses and Orthokeratology Lens Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Myopia Control Spectacle Lenses and Orthokeratology Lens Revenue (2021-2032)
- 7.2.2 North America Myopia Control Spectacle Lenses and Orthokeratology Lens Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Myopia Control Spectacle Lenses and Orthokeratology Lens Revenue (2021-2032)
- 7.3.2 Europe Myopia Control Spectacle Lenses and Orthokeratology Lens Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Myopia Control Spectacle Lenses and Orthokeratology Lens Revenue (2021-2032)
- 7.4.2 Asia-Pacific Myopia Control Spectacle Lenses and Orthokeratology Lens Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Myopia Control Spectacle Lenses and Orthokeratology Lens Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Myopia Control Spectacle Lenses and Orthokeratology Lens Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 HOYA Corporation
- 8.1.1 HOYA Corporation Company Information
- 8.1.2 HOYA Corporation Business Overview
- 8.1.3 HOYA Corporation Myopia Control Spectacle Lenses and Orthokeratology Lens Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 HOYA Corporation Myopia Control Spectacle Lenses and Orthokeratology Lens Product Portfolio
- 8.1.5 HOYA Corporation Recent Developments
- 8.2 ZEISS
- 8.2.1 ZEISS Company Information
- 8.2.2 ZEISS Business Overview
- 8.2.3 ZEISS Myopia Control Spectacle Lenses and Orthokeratology Lens Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 ZEISS Myopia Control Spectacle Lenses and Orthokeratology Lens Product Portfolio
- 8.2.5 ZEISS Recent Developments
- 8.3 CooperVision
- 8.3.1 CooperVision Company Information
- 8.3.2 CooperVision Business Overview
- 8.3.3 CooperVision Myopia Control Spectacle Lenses and Orthokeratology Lens Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 CooperVision Myopia Control Spectacle Lenses and Orthokeratology Lens Product Portfolio
- 8.3.5 CooperVision Recent Developments
- 8.4 EssilorLuxottica
- 8.4.1 EssilorLuxottica Company Information
- 8.4.2 EssilorLuxottica Business Overview
- 8.4.3 EssilorLuxottica Myopia Control Spectacle Lenses and Orthokeratology Lens Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 EssilorLuxottica Myopia Control Spectacle Lenses and Orthokeratology Lens Product Portfolio
- 8.4.5 EssilorLuxottica Recent Developments
- 8.5 Ovctek
- 8.5.1 Ovctek Company Information
- 8.5.2 Ovctek Business Overview
- 8.5.3 Ovctek Myopia Control Spectacle Lenses and Orthokeratology Lens Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Ovctek Myopia Control Spectacle Lenses and Orthokeratology Lens Product Portfolio
- 8.5.5 Ovctek Recent Developments
- 8.6 Alpha Corporation
- 8.6.1 Alpha Corporation Company Information
- 8.6.2 Alpha Corporation Business Overview
- 8.6.3 Alpha Corporation Myopia Control Spectacle Lenses and Orthokeratology Lens Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Alpha Corporation Myopia Control Spectacle Lenses and Orthokeratology Lens Product Portfolio
- 8.6.5 Alpha Corporation Recent Developments
- 8.7 EUCLID
- 8.7.1 EUCLID Company Information
- 8.7.2 EUCLID Business Overview
- 8.7.3 EUCLID Myopia Control Spectacle Lenses and Orthokeratology Lens Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 EUCLID Myopia Control Spectacle Lenses and Orthokeratology Lens Product Portfolio
- 8.7.5 EUCLID Recent Developments
- 8.8 Brighten Optix
- 8.8.1 Brighten Optix Company Information
- 8.8.2 Brighten Optix Business Overview
- 8.8.3 Brighten Optix Myopia Control Spectacle Lenses and Orthokeratology Lens Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Brighten Optix Myopia Control Spectacle Lenses and Orthokeratology Lens Product Portfolio
- 8.8.5 Brighten Optix Recent Developments
- 8.9 Lucid Korea
- 8.9.1 Lucid Korea Company Information
- 8.9.2 Lucid Korea Business Overview
- 8.9.3 Lucid Korea Myopia Control Spectacle Lenses and Orthokeratology Lens Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Lucid Korea Myopia Control Spectacle Lenses and Orthokeratology Lens Product Portfolio
- 8.9.5 Lucid Korea Recent Developments
- 8.10 WeiXing Optical
- 8.10.1 WeiXing Optical Company Information
- 8.10.2 WeiXing Optical Business Overview
- 8.10.3 WeiXing Optical Myopia Control Spectacle Lenses and Orthokeratology Lens Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 WeiXing Optical Myopia Control Spectacle Lenses and Orthokeratology Lens Product Portfolio
- 8.10.5 WeiXing Optical Recent Developments
- 8.11 Contex
- 8.11.1 Contex Company Information
- 8.11.2 Contex Business Overview
- 8.11.3 Contex Myopia Control Spectacle Lenses and Orthokeratology Lens Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Contex Myopia Control Spectacle Lenses and Orthokeratology Lens Product Portfolio
- 8.11.5 Contex Recent Developments
- 8.12 Jiangsu Green Stone Optical (SETO)
- 8.12.1 Jiangsu Green Stone Optical (SETO) Company Information
- 8.12.2 Jiangsu Green Stone Optical (SETO) Business Overview
- 8.12.3 Jiangsu Green Stone Optical (SETO) Myopia Control Spectacle Lenses and Orthokeratology Lens Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Jiangsu Green Stone Optical (SETO) Myopia Control Spectacle Lenses and Orthokeratology Lens Product Portfolio
- 8.12.5 Jiangsu Green Stone Optical (SETO) Recent Developments
- 8.13 Conant
- 8.13.1 Conant Company Information
- 8.13.2 Conant Business Overview
- 8.13.3 Conant Myopia Control Spectacle Lenses and Orthokeratology Lens Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Conant Myopia Control Spectacle Lenses and Orthokeratology Lens Product Portfolio
- 8.13.5 Conant Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Myopia Control Spectacle Lenses and Orthokeratology Lens Value Chain Analysis
- 9.1.1 Myopia Control Spectacle Lenses and Orthokeratology Lens Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Myopia Control Spectacle Lenses and Orthokeratology Lens Production Mode & Process
- 9.2 Myopia Control Spectacle Lenses and Orthokeratology Lens Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Myopia Control Spectacle Lenses and Orthokeratology Lens Distributors
- 9.2.3 Myopia Control Spectacle Lenses and Orthokeratology Lens Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst